Literature DB >> 34730392

Internalization of HIV-1 by Phagocytes Is Increased When Virions Are Opsonized with Multimeric Antibody in the Presence of Complement.

Johannes S Gach1, Stephanie Y Matsuno1, Mayalen Mercado1, Lars Hangartner2, Donald N Forthal1,3.   

Abstract

The low abundance of envelope spikes and the inability of IgG to aggregate virions render HIV-1 an inadequate target for antibody-mediated clearance by phagocytes. In an attempt to improve the ability of antibody to mediate the internalization of HIV-1 virions, we generated multimers of the broadly neutralizing HIV-1-specific monoclonal antibody (MAb) VRC01 using site-directed mutagenesis of the Fc segment. We then measured virion internalization using primary human monocytes and neutrophils. We found that, in the absence of complement, immune complexes consisting of HIV-1 virions and VRC01 multimers were slightly more efficiently internalized than were complexes formed with monomeric VRC01. The presence of complement, however, greatly augmented internalization of immune complexes formed with the multimeric MAb but had little impact on monomeric MAb-mediated internalization. Multimerization and the presence of complement overcome the limited ability of monomeric antibody to mediate internalization of HIV-1 virions and may thus provide a therapeutic approach to clearing virus. IMPORTANCE Antibody-mediated internalization of HIV-1 by phagocytes, a potential mechanism for clearing virus, is very inefficient. In an effort to improve viral clearance, we produced a multimeric form of the broadly neutralizing monoclonal antibody VRC01. We found that VRC01 antibody multimers (primarily hexamers) were only slightly more efficient in mediating HIV-1 internalization than was monomeric VRC01. However, the addition of complement resulted in substantially greater internalization of multimer-opsonized virus. In contrast, complement had little if any impact on internalization of monomer-opsonized virus. Therefore, antibody multimerization in combination with complement may overcome the limited ability of monomeric antibody to mediate internalization of HIV-1 virions. Our findings may provide a therapeutic approach to clearing virus.

Entities:  

Keywords:  Fc receptors; HIV-1; antibody; complement; phagocytosis

Mesh:

Substances:

Year:  2021        PMID: 34730392      PMCID: PMC8791273          DOI: 10.1128/JVI.01689-21

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   6.549


  31 in total

Review 1.  Key principles and methods for studying the endocytosis of biological and nanoparticle therapeutics.

Authors:  Joshua J Rennick; Angus P R Johnston; Robert G Parton
Journal:  Nat Nanotechnol       Date:  2021-03-12       Impact factor: 39.213

2.  Neutrophil extracellular traps mediate a host defense response to human immunodeficiency virus-1.

Authors:  Tatsuya Saitoh; Jun Komano; Yasunori Saitoh; Takuma Misawa; Michihiro Takahama; Tatsuya Kozaki; Takuya Uehata; Hidenori Iwasaki; Hiroko Omori; Shoji Yamaoka; Naoki Yamamoto; Shizuo Akira
Journal:  Cell Host Microbe       Date:  2012-07-19       Impact factor: 21.023

3.  Molecular Basis of Assembly and Activation of Complement Component C1 in Complex with Immunoglobulin G1 and Antigen.

Authors:  Guanbo Wang; Rob N de Jong; Ewald T J van den Bremer; Frank J Beurskens; Aran F Labrijn; Deniz Ugurlar; Piet Gros; Janine Schuurman; Paul W H I Parren; Albert J R Heck
Journal:  Mol Cell       Date:  2016-06-16       Impact factor: 17.970

4.  Primary Human Neutrophils Exhibit a Unique HIV-Directed Antibody-Dependent Phagocytosis Profile.

Authors:  Rebecca L R Powell; Alisa Fox; Vincenza Itri; Susan Zolla-Pazner
Journal:  J Innate Immun       Date:  2018-12-17       Impact factor: 7.349

5.  Protective efficacy of adenovirus/protein vaccines against SIV challenges in rhesus monkeys.

Authors:  Dan H Barouch; Galit Alter; Thomas Broge; Caitlyn Linde; Margaret E Ackerman; Eric P Brown; Erica N Borducchi; Kaitlin M Smith; Joseph P Nkolola; Jinyan Liu; Jennifer Shields; Lily Parenteau; James B Whitney; Peter Abbink; David M Ng'ang'a; Michael S Seaman; Christy L Lavine; James R Perry; Wenjun Li; Arnaud D Colantonio; Mark G Lewis; Bing Chen; Holger Wenschuh; Ulf Reimer; Michael Piatak; Jeffrey D Lifson; Scott A Handley; Herbert W Virgin; Marguerite Koutsoukos; Clarisse Lorin; Gerald Voss; Mo Weijtens; Maria G Pau; Hanneke Schuitemaker
Journal:  Science       Date:  2015-07-02       Impact factor: 47.728

Review 6.  Immune correlates of vaccine protection against HIV-1 acquisition.

Authors:  Lawrence Corey; Peter B Gilbert; Georgia D Tomaras; Barton F Haynes; Giuseppe Pantaleo; Anthony S Fauci
Journal:  Sci Transl Med       Date:  2015-10-21       Impact factor: 17.956

7.  Human immunodeficiency virus type-1 (HIV-1) evades antibody-dependent phagocytosis.

Authors:  Johannes S Gach; Margaux Bouzin; Marcus P Wong; Veronika Chromikova; Andrea Gorlani; Kuan-Ting Yu; Brijesh Sharma; Enrico Gratton; Donald N Forthal
Journal:  PLoS Pathog       Date:  2017-12-27       Impact factor: 6.823

8.  Broadly neutralizing human anti-HIV antibody 2G12 is effective in protection against mucosal SHIV challenge even at low serum neutralizing titers.

Authors:  Ann J Hessell; Eva G Rakasz; Pascal Poignard; Lars Hangartner; Gary Landucci; Donald N Forthal; Wayne C Koff; David I Watkins; Dennis R Burton
Journal:  PLoS Pathog       Date:  2009-05-15       Impact factor: 6.823

9.  Neutrophil isolation protocol.

Authors:  Hana Oh; Brian Siano; Scott Diamond
Journal:  J Vis Exp       Date:  2008-07-23       Impact factor: 1.355

10.  Pentavalent HIV-1 vaccine protects against simian-human immunodeficiency virus challenge.

Authors:  Todd Bradley; Justin Pollara; Sampa Santra; Nathan Vandergrift; Srivamshi Pittala; Chris Bailey-Kellogg; Xiaoying Shen; Robert Parks; Derrick Goodman; Amanda Eaton; Harikrishnan Balachandran; Linh V Mach; Kevin O Saunders; Joshua A Weiner; Richard Scearce; Laura L Sutherland; Sanjay Phogat; Jim Tartaglia; Steven G Reed; Shiu-Lok Hu; James F Theis; Abraham Pinter; David C Montefiori; Thomas B Kepler; Kristina K Peachman; Mangala Rao; Nelson L Michael; Todd J Suscovich; Galit Alter; Margaret E Ackerman; M Anthony Moody; Hua-Xin Liao; Georgia Tomaras; Guido Ferrari; Bette T Korber; Barton F Haynes
Journal:  Nat Commun       Date:  2017-06-08       Impact factor: 17.694

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.